Impaired Tight Junctions in Atopic Dermatitis Skin and in a Skin-Equivalent Model Treated with Interleukin-17
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Tight junction (TJ) dysfunction in the stratum granulosum leads to aberrant barrier function of the stratum corneum (SC) in the epidermis. However, it is unclear whether TJs are perturbed in atopic dermatitis (AD), a representative aberrant SC-related skin disease, and whether some factors related to AD pathogenesis induce TJ dysfunction. To address these issues, we investigated the alterations of TJs in AD skin and the effects of Th2 and Th17 cytokines on TJs in a skin-equivalent model. The levels of TJ proteins were determined in the epidermis of nonlesional and lesional skin sites of AD. Western blot and immunohistochemical analyses revealed that the levels of zonula occludens 1 were decreased in the nonlesional sites of AD, and the levels of zonula occludens 1 and claudin-1 were decreased in the lesional sites relative to the levels in skin from healthy subjects. Next, we examined the effects of interleukin (IL)-4, tumor necrosis factor-α, IL-17, and IL-22 on the TJ barrier in a skin-equivalent model. Only IL-17 impaired the TJ barrier. Furthermore, we observed a defect in filaggrin monomer degradation in the IL-17-treated skin model. Thus, TJs are dysfunctional in AD, at least partly, due to the effect of IL-17, which may result in an aberrant SC barrier.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Palmer, C. N. A., Irvine, A. D., Terron-Kwiatkowski, A., Zhao, Y., Liao, H., Lee, S. P., Goudie, D. R., Sandilands, A., Campbell, L. E., Smith, F. J. D., et al. (2006) · Nature Genetics · doi:10.1038/ng1767 · Cited by 2,978 · cited 1×
“Loss-of-function mutations in the gene encoding filaggrin contribute to barrier perturbation [16], and filaggrin expression is significantly reduced in patients with AD even without filaggrin mutations [17].”
BackgroundClaudin-based tight junctions are crucial for the mammalian epidermal barrier
Furuse, M., Hata, M., Furuse, K., Yoshida, Y., Haratake, A., Sugitani, Y., Noda, T., Kubo, A., & Tsukita, S. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200110122 · Cited by 1,512 · cited 5×
“When an intercellular tracer is injected into the epidermis from the dermal side, it diffuses through most of the paracellular space but is blocked at positions where constitutive TJ proteins are coassembled [5,6].”
BackgroundMethodInfluentialScratching the surface of skin development
Fuchs, E. (2007) · Nature · doi:10.1038/nature05659 · Cited by 930 · cited 1×
“stratum corneum (SC) is largely responsible for this vital barrier function [3].”
BackgroundOne remarkable molecule: filaggrin
Brown, S. J., & Irwin McLean, W. H. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.393 · Cited by 527 · cited 1×
“However, 10% of the human population harbors filaggrin mutations, although far fewer people develop AD [19,20], which suggests that some factors other than filaggrin are deeply involved in the barrier dysfunction.”
BackgroundAltered stratum corneum barrier and enhanced percutaneous immune responses in filaggrin-null mice
Kawasaki, H., Nagao, K., Kubo, A., Hata, T., Shimizu, A., Mizuno, H., Yamada, T., & Amagai, M. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.01.068 · Cited by 301
Brandner, J. M., Kief, S., Grund, C., Rendl, M., Houdek, P., Kuhn, C., Tschachler, E., Franke, W. W., & Moll, I. (2002) · European Journal of Cell Biology · doi:10.1078/0171-9335-00244 · Cited by 289 · cited 2×
“Representative immunolabeling of claudin-1, claudin-4, occludin, and ZO-1 (Fig 1A) in healthy skin detected the localization of claudin-1 protein from the basal to granular layers of the epidermis and that of claudin-4 in the granular layer, as reported previously [4,6].”
BackgroundResultContribution of Tight Junction Proteins to Ion, Macromolecule, and Water Barrier in Keratinocytes
Kirschner, N., Rosenthal, R., Furuse, M., Moll, I., Fromm, M., & Brandner, J. M. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.507 · Cited by 182
Yuki, T., Hachiya, A., Kusaka, A., Sriwiriyanont, P., Visscher, M. O., Morita, K., Muto, M., Miyachi, Y., Sugiyama, Y., & Inoue, S. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.385 · Cited by 113
Self-citation
Cited by
Guttman-Yassky, E., Bissonnette, R., Ungar, B., Suárez-Fariñas, M., Ardeleanu, M., Esaki, H., Suprun, M., Estrada, Y., Xu, H., Peng, X., et al. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.08.022 · Cited by 697
The Dynamics of the Skin’s Immune System
Nguyen, A. V., & Soulika, A. M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081811 · Cited by 694
Atopic Dermatitis: Pathophysiology
David Boothe, W., Tarbox, J. A., & Tarbox, M. B. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-64804-0_3 · Cited by 463
The epithelial immune microenvironment (EIME) in atopic dermatitis and psoriasis
Dainichi, T., Kitoh, A., Otsuka, A., Nakajima, S., Nomura, T., Kaplan, D. H., & Kabashima, K. (2018) · Nature Immunology · doi:10.1038/s41590-018-0256-2 · Cited by 395
Brunner, P. M., Israel, A., Zhang, N., Leonard, A., Wen, H.-C., Huynh, T., Tran, G., Lyon, S., Rodriguez, G., Immaneni, S., et al. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.02.040 · Cited by 256
Three-Dimensional Cell Cultures: The Bridge between In Vitro and In Vivo Models
Urzì, O., Gasparro, R., Costanzo, E., De Luca, A., Giavaresi, G., Fontana, S., & Alessandro, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512046 · Cited by 224
Niehues, H., Bouwstra, J. A., El Ghalbzouri, A., Brandner, J. M., Zeeuwen, P. L. J. M., & van den Bogaard, E. H. (2018) · Experimental Dermatology · doi:10.1111/exd.13531 · Cited by 210
Immortalized N/TERT keratinocytes as an alternative cell source in 3D human epidermal models
Smits, J. P. H., Niehues, H., Rikken, G., van Vlijmen-Willems, I. M. J. J., van de Zande, G. W. H. J. F., Zeeuwen, P. L. J. M., Schalkwijk, J., & van den Bogaard, E. H. (2017) · Scientific Reports · doi:10.1038/s41598-017-12041-y · Cited by 205
Rerknimitr, P., Otsuka, A., Nakashima, C., & Kabashima, K. (2017) · Inflammation and Regeneration · doi:10.1186/s41232-017-0044-7 · Cited by 187
“Importantly, TJ aberration is associated with AD since human AD epidermis has a reduced expression of claudin-1, claudin-23 [29], and ZO-1 [30] and shows evidence of impaired barrier function.”
BackgroundCytokine-Mediated Crosstalk Between Keratinocytes and T Cells in Atopic Dermatitis
Humeau, M., Boniface, K., & Bodet, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.801579 · Cited by 75
Fernando, I. P. S., Dias, M. K. H. M., Madusanka, D. M. D., Han, E. J., Kim, M. J., Heo, S.-J., Lee, K., Cheong, S. H., & Ahn, G. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.11.115 · Cited by 48
In Vitro and Ex Vivo Models for Screening Topical Anti-Inflammatory Drugs
Pérez-Salas, J. L., Moreno-Jiménez, M. R., Rocha-Guzmán, N. E., González-Laredo, R. F., Medina-Torres, L., & Gallegos-Infante, J. A. (2023) · Scientia Pharmaceutica · doi:10.3390/scipharm91020020 · Cited by 22
“For example, the skin of patients with atopic dermatitis showed decreased expression of zonule binding molecules-1 and claudin-1 [13].”
Background
Metadata
- Authors
- Yuki, T., Tobiishi, M., Kusaka-Kikushima, A., Ota, Y., & Tokura, Y.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2016-09-02
- Volume
- 11
- Issue
- 9
- Pages
- e0161759
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2511616479
- Cited by
- 147
- References
- 8
- FWCI
- 15.07
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.